Analystreport

Satsuma Pharmaceuticals (NASDAQ: STSA) had its price target lowered by analysts at HC Wainwright from $35.00 to $7.00. They now have a "buy" rating on the stock.

Satsuma Pharmaceuticals, Inc. - Common stock  (STSA) 
Last satsuma pharmaceuticals, inc. - common stock earnings: 3/10 04:01 pm Check Earnings Report